Fluoxetine in the treatment of borderline and schizotypal personality disorders

Am J Psychiatry. 1991 Aug;148(8):1064-7. doi: 10.1176/ajp.148.8.1064.

Abstract

Twenty-two patients meeting the criteria for borderline or schizotypal personality disorder or both participated in a prospective, nonblind 12-week trial of fluoxetine. There were significant reductions in self-injury and in scores on the Hopkins Symptom Checklist regardless of diagnosis. The results suggest that controlled trials of fluoxetine and investigations of the serotonergic system in these disorders would be useful.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Borderline Personality Disorder / drug therapy*
  • Borderline Personality Disorder / physiopathology
  • Borderline Personality Disorder / psychology
  • Chronic Disease
  • Drug Administration Schedule
  • Female
  • Fluoxetine / administration & dosage
  • Fluoxetine / therapeutic use*
  • Humans
  • Male
  • Personality Inventory
  • Prospective Studies
  • Schizotypal Personality Disorder / drug therapy*
  • Schizotypal Personality Disorder / physiopathology
  • Schizotypal Personality Disorder / psychology
  • Self Mutilation / prevention & control
  • Serotonin / physiology

Substances

  • Fluoxetine
  • Serotonin